Table 2. Hospital therapies .
| Variables | All (N = 2766) | DM (N = 1000) | Non-DM (N = 1766) | p-value |
| Aspirin (%) | 2535 (91.6) | 890 (89) | 1645 (93.1) | < 0.001 |
| Clopidogrel (%) | 2610 (94.4) | 926 (92.6) | 1684 (95.4) | 0.003 |
| ACEI (%) | 1360 (49.2) | 435 (43.5) | 925 (52.4) | < 0.001 |
| ARB (%) | 343 (12.4) | 165 (16.5) | 178 (10.1) | < 0.001 |
| Renin-angiotensin blocker (%) | 1630 (58.93) | 567 (56.7) | 1063 (60.2) | 0.07 |
| B-blocker (%) | 1264 (45.7) | 465 (46.5) | 799 (45.2) | 0.52 |
| Statin (%) | 1370 (49.5) | 497 (49.7) | 873 (49.4) | 0.89 |
| Thrombolysis (%) | 47 (2.5) | 15 (2.4) | 32 (2.5) | 0.88 |
| Primary PCI (%) | 1316 (90.8) | 390 (89.2) | 926 (91.5) | < 0.001 |
| PCI (%) | 2371 (85.9) | 819 (82.2) | 1552 (87.9) | < 0.001 |
| CABG (%) | 93 (3.4) | 44 (4.4) | 49 (2.8) | 0.02 |
a. Chi-square test or Fisher's exact test. b. Independent t test or Mann-Whitney U test.
ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin II receptor blocker; CABG, coronary artery bypass graft; PCI, percutaneous coronary intervention; renin-angiotensin blocker includes ACEI and ARB.